Switch theme
Sign up to access all valuation multiples
Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. Company operates in USA, Germany, Australia, Switzerland, and Sweden. Majority of revenue is from USA.
1999
136
LTM Revenue $3.0M
LTM EBITDA -$66.8M
$154M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Anteris Technologies US has a last 12-month revenue of $3.0M and a last 12-month EBITDA of -$66.8M.
In the most recent fiscal year, Anteris Technologies US achieved revenue of $2.7M and an EBITDA of -$74.6M.
Anteris Technologies US expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Anteris Technologies US valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $2.8M | $2.7M | XXX | XXX | XXX |
| Gross Profit | $1.8M | $1.7M | XXX | XXX | XXX |
| Gross Margin | 63% | 63% | XXX | XXX | XXX |
| EBITDA | -$45.1M | -$74.6M | XXX | XXX | XXX |
| EBITDA Margin | -1609% | -2761% | XXX | XXX | XXX |
| Net Profit | -$30.2M | -$45.9M | XXX | XXX | XXX |
| Net Margin | -1077% | -1697% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 24, 2025, Anteris Technologies US's stock price is $4.
Anteris Technologies US has current market cap of $161M, and EV of $154M.
See Anteris Technologies US trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $154M | $161M | XXX | XXX | XXX | XXX | $-2.65 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 24, 2025, Anteris Technologies US has market cap of $161M and EV of $154M.
Anteris Technologies US's trades at 51.4x LTM EV/Revenue multiple, and -2.3x LTM EBITDA.
Analysts estimate Anteris Technologies US's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Anteris Technologies US and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $154M | XXX | XXX | XXX |
| EV/Revenue | 56.8x | XXX | XXX | XXX |
| EV/EBITDA | -2.1x | XXX | XXX | XXX |
| P/E | -2.1x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -2.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAnteris Technologies US's NTM/LTM revenue growth is 90%
Anteris Technologies US's revenue per employee for the last fiscal year averaged $20K, while opex per employee averaged $0.6M for the same period.
Over next 12 months, Anteris Technologies US's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Anteris Technologies US's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Anteris Technologies US and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -3% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -2761% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 66% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -2670% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $20K | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.6M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 1043% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 1903% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 2994% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Anteris Technologies US acquired XXX companies to date.
Last acquisition by Anteris Technologies US was XXXXXXXX, XXXXX XXXXX XXXXXX . Anteris Technologies US acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Anteris Technologies US founded? | Anteris Technologies US was founded in 1999. |
| Where is Anteris Technologies US headquartered? | Anteris Technologies US is headquartered in United States of America. |
| How many employees does Anteris Technologies US have? | As of today, Anteris Technologies US has 136 employees. |
| Is Anteris Technologies US publicy listed? | Yes, Anteris Technologies US is a public company listed on NAS. |
| What is the stock symbol of Anteris Technologies US? | Anteris Technologies US trades under AVR ticker. |
| When did Anteris Technologies US go public? | Anteris Technologies US went public in 2024. |
| Who are competitors of Anteris Technologies US? | Similar companies to Anteris Technologies US include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Anteris Technologies US? | Anteris Technologies US's current market cap is $161M |
| What is the current revenue of Anteris Technologies US? | Anteris Technologies US's last 12-month revenue is $3.0M. |
| What is the current EBITDA of Anteris Technologies US? | Anteris Technologies US's last 12-month EBITDA is -$66.8M. |
| What is the current EV/Revenue multiple of Anteris Technologies US? | Current revenue multiple of Anteris Technologies US is 51.4x. |
| What is the current EV/EBITDA multiple of Anteris Technologies US? | Current EBITDA multiple of Anteris Technologies US is -2.3x. |
| What is the current revenue growth of Anteris Technologies US? | Anteris Technologies US revenue growth between 2023 and 2024 was -3%. |
| Is Anteris Technologies US profitable? | Yes, Anteris Technologies US is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
